10 December 2026 re-tender around October 2026 |
2025/1303 - Acalabrutinib [100 mg cáp/comp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
ASTRAZENECA- PROD.FARM LDA 1 bid received |
€232,935 |
23 December 2026 re-tender around October 2026 |
2026/0006 - Olaparib [150 mg cáp/ comp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
ASTRAZENECA- PROD.FARM LDA 1 bid received |
€266,176 |
23 December 2026 re-tender around October 2026 |
2023/0491 - Osimertinib [80 mg comp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
ASTRAZENECA- PROD.FARM LDA 1 bid received |
€2,221,439 |
23 December 2026 re-tender around October 2026 |
2023/0492 - Durvalumab [50 mg/ ml 10 ml frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
ASTRAZENECA- PROD.FARM LDA 1 bid received |
€684,601 |
23 December 2026 re-tender around October 2026 |
2025/1303 - Acalabrutinib [100 mg cáp/comp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
ASTRAZENECA- PROD.FARM LDA 1 bid received |
€229,116 |
23 December 2026 re-tender around October 2026 |
2024/0899 - Benralizumab [30 mg/1 ml sol inj caneta/ seringa]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
ASTRAZENECA- PROD.FARM LDA 1 bid received |
€613,531 |
25 December 2026 re-tender around October 2026 |
2025/1303 - Acalabrutinib [100 mg cáp/comp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
ASTRAZENECA- PROD.FARM LDA 1 bid received |
€305,488 |
27 December 2026 re-tender around October 2026 |
2023/0492 - Durvalumab [50 mg/ ml 10 ml frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
ASTRAZENECA- PROD.FARM LDA 1 bid received |
€295,511 |
28 December 2026 re-tender around October 2026 |
2024/0899 - Benralizumab [30 mg/1 ml sol inj caneta/ seringa]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
ASTRAZENECA- PROD.FARM LDA 1 bid received |
€137,769 |